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With the publication in 1972 of a large computer model of circulatory control, Guyton and
colleagues challenged the then prevailing views on how blood pressure and cardiac output were
controlled. At that time, it was widely accepted that the heart controlled cardiac output and
that peripheral resistance controlled arterial blood pressure. By incorporating the empirically
demonstrated concepts of blood ﬂow autoregulation and the pressure–natriuresis relationship
into their mathematical model, Guyton and colleagues were able to develop a number of
revolutionary concepts. Guyton’s circulatory model was particularly instrumental in exploring
the linkage between blood pressure and sodium balance and in demonstrating an overriding
importance of renal salt and water balance in setting the long-term blood pressure level. In
both the model and experimental data, any long-lasting imbalance between salt intake and salt
excretion leads to a progressive alteration of the degree of ﬁlling of the vascular system and
thus to parallel changes in blood pressure. In turn, changes in blood pressure alter sodium
excretion, opposing the initial salt imbalance. Although Guyton’s model does not include the
most recent cardiovascular discoveries, the concepts underlying the basic functioning of the
cardiovascular system can serve as a well-built basis for the development of new, large and
integrative cardiovascular models.
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A short history of the development of Guyton’s model
In 1972, Guyton, Coleman and Granger published a
detailed description of a large computer model of
circulatory control (Guyton et al. 1972). The model
consisted of several hundred mathematical equations
aiming primarily at understanding the long-term
regulation of blood pressure (BP) and cardiac output
(CO). In the late 1950s, when Guyton started to be
quite proliﬁc in the ﬁeld of physiology, considerable
controversy existed concerning the regulation of these
major cardiovascular variables. The two prevailing views
in cardiovascular control were: (a) that the heart controls
CO (cardiocentric view); and (b) that vascular resistance
controls BP (vasculocentric view).
The early contributions of Guyton (Guyton et al. 1959)
challenged the cardiocentric view. Guyton used a circuit
analysis based on simple physical laws of pressure–ﬂow
and pressure–volume relationships to dissect the major
factors affecting the return of blood to the heart. Later,
after investigating the manner in which the heart function
is coupled to venous circulation, Guyton established
the now classical graphical analysis of CO and venous
return (Guyton et al. 1973), the principles of which were
incorporated into his 1972 model and remain today a
powerfuldidactic tool to explainCOregulation ina steady-
state situation. While more advanced models of cardiac
functionhave subsequently beendeveloped (e.g. pressure–
volume analysis), the coupling of the heartwith the venous
circulation remains a core feature of modern circulatory
models.
Guyton and colleagues’ investigation of the linkage
between the regulation of extracellular ﬂuid volume
(ECFV) and that of BP also strongly challenged the
vasculocentric viewpoint. Extending traditional models
consisting of circulatory pressures, ﬂows and resistances,
they added circulatory volumes and compliances and
linked themto sourcesofﬂuidentry (absorptionof salt and
water by the digestive tract) and loss (chieﬂy salt andwater
excretionby the kidney).Analysis of themodel’s behaviour
revealed an overriding importance of the relative ﬁlling of
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the vascular system in the feedback regulation of the long-
termBP level. Any sustained imbalance between salt intake
and salt excretion caused a change in the degree of ﬁlling
of the vascular system and, in turn, parallel alterations in
BP. This effect was opposed by the demonstrated ability of
changes in BP to cause corresponding alterations in renal
sodium excretion, the so-called acute pressure–natriuresis
relationship (PNR). Consequently, the long-term mean
BP was found to represent the one BP level at which these
effects were balanced, i.e. the one pressure level at which
salt balance (intake = output) could be achieved. Thus,
Guyton and colleagues came to realize that BP regulation
was intimately linked with ﬂuid volume regulation,
and that the long-term BP was controlled at a level
predicted by the PNR and not by the vascular resistance
per se.
With the 1972 publication of the large circulatory
model, Guyton and colleagues paved the way to new
thinking in the regulation of cardiovascular dynamics.
The model was written in FORTRAN and ran initially
on a large minicomputer (ﬁrst on a PDP 9, from
Digital Equipment Corporation, then in the mid-
1970s on a PDP 11/70). It was later transferred into
the personal computer environment (Montani et al.
1989a,b), where it could be made freely available
to the scientiﬁc community. Following 1972, Guyton
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Figure 1. The renal body ﬂuid feedback mechanism for control of blood volume and extracellular ﬂuid
volume in the face of large changes in salt intake
See text for a detailed explanation of each block (A–G) of the block-diagram. Abbreviations: ECFV, extracellular
ﬂuid volume; MCFP, mean circulatory ﬁlling pressure; RAtP, right atrial pressure; CO, cardiac output; EP, equilibrium
point; TPR, total peripheral resistance; and BP, blood pressure.
continued to revise the model, mainly by developing
the kidney components and incorporating more recent
cardiovascular discoveries. However, the main features of
the 1972 version (e.g. pressure–natriuresis relationship,
blood ﬂow autoregulation) remained as core concepts of
the model. Guyton made very few additions to his model
after his retirement in 1989 at the age of 70. He died in
2003, leaving behind the most recent version of his model
dating from 1992.
Why does the kidney play a dominant role
in long-term blood pressure control?
In Guyton’s model, control of BP and sodium balance
are tightly linked via the acute pressure–natriuresis
relationship, a concept so central to the regulation
of sodium excretion that the many other factors
and mechanisms that inﬂuence sodium excretion were
considered by Guyton to act chieﬂy by modifying this
relationship (Guyton, 1980). Based on this concept, one
can understand the general renal body ﬂuid feedback
mechanism (Guyton et al. 1972; Guyton, 1980, 1990; Hall
et al. 1986a) as illustrated in the block-diagram of Fig. 1.
Any imbalance between intake and output of salt will lead
to a cascade of events that oppose the initial disturbance, a
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classical negative feedback loop. For example, if salt intake
is greater than salt excretion (Fig. 1A), there is a positive
rate of change of the ECFV (ECFV) which, integrated
over time (Fig. 1B), results in an increase in ECFV and,
in turn, to an increase in blood volume (Fig. 1C). The
greater blood volume increases mean circulatory ﬁlling
pressure (MCFP, which represents the degree of ﬁlling of
the whole circulation, relating blood volume to vascular
capacity), as shownby the relationship depicted in Fig. 1D.
This results in a right and upward shift of the equilibrium
point (Fig. 1E) in Guyton’s classic graphical analysis of
the cardiac function curve and the venous return curve
(Guyton et al. 1973), yielding both an increase in right
atrial pressure and an increase in venous return. The
resulting increase in cardiac output raises BP (Fig. 1F). In
turn, by way of the acute pressure–natriuresis mechanism,
the higher BP increases salt output (Fig. 1G), which
opposes the effects of the initial increase in salt intake.
Being dependent on ﬂuid volume changes, this system
is inherently slow (hours or days). However, because the
underlying changes in ﬂuid volume accumulate over time
until BP reaches a point at which salt balance is achieved,
this feedback system is extremely effective. Theoretically,
if given a sufﬁcient period of time, such a system could
completely correct any error in salt balance or blood
pressure.
It should be noted that the acute pressure–natriuresis
curve (PNC) depicted in Fig. 1G and Fig. 2A is not
immovable, but can be modulated by a number of factors
and conditions including changes in salt intake. For
example, it becomes steeper and is shifted to the left
during high salt intake (Fig. 2B). Conversely, during low
Figure 2. The concept of the acute pressure–natriuresis relationship and how adjustments of this
relationship facilitate sodium balance during sustained changes in salt intake
Equilibrium is reached at the intersection between the acute pressure–natriuresis curve (PNC) and the corresponding
level of salt excretion that matches salt intake. A, with a ﬁxed PNC, equilibrium for the three depicted levels of salt
intake (1 × normal, 4 × normal and 0.2 × normal) would be reached at points A, B and C, respectively, yielding
considerable salt sensitivity. B, after adjustments of the PNC with varying salt intakes (left-shift with steepening at
high-salt intake, right-shift with ﬂattening at low-salt intake), joining the intersection points (B′, A and C′) reveals
an almost vertical chronic pressure–natriuresis relationship (see dotted line), i.e. the chronic renal function curve.
The modulation of the acute PNC during alterations in salt intakes thus allows the body to achieve sodium balance
with minimal changes in arterial pressure.
salt intake, the PNC becomes ﬂatter and is shifted to the
right. Joining the equilibrium points at the various salt
intakes now reveals a very steep steady-state relationship
with little change in BP (the chronic pressure–natriuresis
relationship or ‘renal function curve’). That is, BP has
become relatively salt insensitive. Various neurohormonal
mechanisms contribute to the adjustment of the acute
PNC with varying salt intakes, such as sympathetic
activity, natriuretic and antinatriuretic hormones. Above
all, modulation of the renin–angiotensin system (RAS)
plays a crucial role in the adaptation to changes in salt
intake, with suppression of the RAS at high salt intake
facilitating sodium excretion and stimulation of the RAS
at low salt intake contributing to sodium conservation
(Montani & Van Vliet, 2004). In summary, the great
sensitivity of the acute PNC to neurohumoral modulation
can explain how sodium balance can be defended with
little or no change in BP.
Several lines of evidence are consistent with the central
role of the kidney in long-term BP control, as follows.
• First, inability to modulate the pressure–natriuresis
curve leads to salt sensitivity. Indeed, dramatic salt-
induced changes in BP occur when the RAS is blocked
with an angiotensin-converting enzyme inhibitor or
when circulating angiotensin II levels are ﬁxed with an
intravenous infusion of angiotensin II (Hall et al. 1980).
• Second, most renal transplantation studies support
the notion that the kidney is a major determinant of
long-term BP (Rettig, 1993). This concept is reinforced
by a recent study in an experimental model of kidney
cross-transplantation in the mouse, which shows that
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angiotensin II causes hypertension through its receptors
in the kidney (Crowley et al. 2006).
• Third, in various experimental models of hormone-
induced hypertension [e.g. due to infusion of aldosterone
(Hall et al. 1984b), angiotensin II (Hall et al. 1984a),
vasopressin (Hall et al. 1986b) or noradrenaline (Hall et al.
1988)], shielding the kidney from the hormone-induced
increase in BP (i.e. holding renal perfusion pressure near
control levels) leads tomarked ﬂuid retention that persists
throughout the infusion period despite larges increases in
ECFV and severe systemic hypertension.
• Fourth, experiments in dogs instrumented for
separatemonitoringof left and right kidney functionshave
shown that the acute pressure–natriuresis relationship
does not reset during long-term changes in arterial
pressure (Mizelle et al. 1993).
• Finally, support for the role of BP in the control
of sodium balance comes from genetic studies. Many
genes have been identiﬁed to be associated with essential
hypertension or responsible for rare monogenic diseases
that are characterized by low or high blood pressures
(Lifton et al. 2001; Mullins et al. 2006). Intriguingly, most
of these genes encode proteins that are directly involved
with renal sodium handling. Mutations that favour renal
sodium reabsorption increase BP, whereas mutations that
diminish tubular sodiumreabsorption tend todecreaseBP.
Changes in BP seem thus to be a homeostatic mechanism
to achieve sodium balance in the face of excessive or
deﬁcient salt reabsorption.
Some common misconceptions in understanding
Guyton’s model
Guyton limited the size of his model to several hundred
equations in order to focus on the mechanisms that were
most important in long-term control of BP and ﬂuid
volumes. Nevertheless, understanding his model requires
that a number of components and concepts must be
kept in mind simultaneously. This inherent complexity
has occasionally led to misconceptions and apparent
paradoxes that are worth clarifying.
Misconception 1: a primary renal dysfunction is at
the origin of all forms of hypertension. According to
Guyton’s analysis of BP regulation, any long-lasting
alteration in BP requires a shift of the PNR (assuming
salt intake is constant). However, a shift of the PNR
does not need to be the primary event in the cascade of
changes leading to hypertension; it can also be secondary
to non-renal inﬂuences. Indeed, Guyton’s model allows
one to simulate many forms of hypertension of extrarenal
origin, including a mineralocorticoid-producing tumour,
coarctation of the aorta or even sympathetic overactivity.
However, the model predicts that, whatever the cause
of hypertension, it must in the end somehow modify
the kidney’s ability to excrete salt and water for a given
level of BP; otherwise, the hypertension would lead to
an increased excretion of salt and water through the PNR,
ultimately returningBP to regular levels. Even the escape to
the sodium-retaining effects of servo-controlled low renal
perfusion pressure (Reinhardt et al. 1994), an experiment
often suggested to challenge Guyton’s body ﬂuid feed-
back mechanism, can be explained by a leftward shift of
the PNC as a consequence of volume expansion, systemic
hypertension, suppression of antinatriuretic factors and
stimulation of natriuretic factors (Montani & Van Vliet,
2007). Furthermore, in many instances, overt changes
in BP are not required to achieve sodium balance.
Indeed, a number of autocrine and paracrine factors
generated within the kidney itself can inﬂuence renal
sodium excretion. However, conceptually, these short-
loop feedbacks are equivalent to a shift of the PNC.
Misconception 2: Guyton’s model dismisses the role
of the central nervous system in long-term blood-
pressure regulation. Although Guyton’s model contains
only a rudimentary representation of central nervous
system (CNS) function (limited to basic cardiovascular
reﬂexes, such as baroreceptors, chemoreceptors and
central ischaemic reﬂex), Guyton left open a possible
role of the CNS in long-term BP control. In his
original 1972 description of his system’s analysis and
model, he noted suggestions by earlier authors that
neurogenic hypertension could be mediated through a
nervous inﬂuence on renal function. Subsequently, he
provided analyses and model simulations illustrating how
sustained hypertension could be induced by activation of
sympathetic nerves throughout the body, or to the kidney
alone, but that such effects did not occur if the sympathetic
outﬂow to the kidney was excluded (ﬁgures 35-1 through
35-3 of Guyton, 1980).
In Guyton’s model, the direct effects of sympathetic
stimulation are limited to renal effects, constriction of
the vasculature and to increasing heart performance.
The model does not exclude the possibility that
sympathetic stimulation of non-renal tissues could
also alter kidney function by other mechanisms,
including an inﬂuence on circulating mediators (e.g.
endothelin, digitalis glycosides and immune system
components). It is also very possible that the CNS could
alter renal function and BP by mechanisms other than
sympathetic activation. Indeed, the CNS is known to
release a number of substances that inﬂuence renal
function (vasopressin, adrenocorticotrophic hormone,
γ-melanocyte-stimulating hormone and digitalis
glycosides) and others may remain to be identiﬁed.
However, whatever the role of the CNS, Guyton’s analyses
suggest that any inﬂuence on the long-term BP level
would imply a ﬁnal pathway acting on the kidney.
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Misconception 3: changes in mean arterial pressure must
be linked to changes in total blood volume. Although
the analysis of Fig. 1 shows that ECFV and blood volume
are essential components of long-term regulation of BP,
a more careful examination reveals that the BP is not a
function of total blood volume per se but of the ‘volume in
excess’ in the vascular tree (i.e. the distending volume in
excess of the resting size of the vasculature), particularly
in the arterial tree. This concept is analogous to the
concept of effective arterial blood volume used by others
(Schrier, 1990). With this in mind, one can easily see why
the renal body ﬂuid feedback mechanism also applies to
hypertensionmodels characterizedby a lowbloodvolume,
such as noradrenaline-induced hypertension (Hall et al.
1988) or administration of angiotensin II at higher doses
(Carroll et al. 1984).
On the one hand, one would expect noradrenaline
or angiotensin to promote sodium retention by acting
directly on the kidney and thereby increasing total blood
volume. On the other hand, both agents are also strong
vasoconstrictors that increase BP rapidly, leading to initial
natriuresis and thus to a decrease in blood volume. In
parallel, these vasoconstrictor agents decrease vascular
capacitance, permitting the maintenance of a high BP
value with a low blood volume. Simulation of these
hypertensive states with Guyton’s model reveals a state
of overﬁlling of the circulation, with increased MCFP and
arterial volume in excess despite a decreased total blood
volume.
Misconception 4: whole body blood ﬂow autoregulation
is the cause of volume-loading hypertension. Auto
regulation is the ability of an organ or tissue to adjust
its blood ﬂow by local mechanisms, in accordance with
local needs, and is often evident in the relative consistency
of tissue blood ﬂow despite changes in perfusion pressure.
In the intact circulation, volume-loading elevates CO and
thus BP. The resulting overperfusion of the tissues leads
then to secondary autoregulatory changes in vascular
resistance (Coleman & Guyton, 1969). Unfortunately,
this ‘whole body’ form of autoregulation is often
misinterpreted as the cause of systemic hypertension
during volume-loading. However, autoregulation lies
outside of the main feedback loop of the renal body ﬂuid
feedback mechanism, as shown in Fig. 1. Consequently,
the renal body ﬂuid feedback mechanism is expected to
act to regulate the long-term BP level in order to achieve
sodium balance irrespective of the level of total peripheral
resistance. By opposing pressure-induced distension of
arterioles, autoregulation greatly reduces the change in
ECFV, blood volume and CO that would otherwise be
required to increase BP in order to achieve sodiumbalance
(Guyton et al. 1988). Thus, autoregulation converts
an initial high-CO hypertension into a high-resistance
hypertension, thus allowing the renal body ﬂuid feedback
mechanism to regulate the long-term BP level in a highly
effective manner without the need for the large changes in
ﬂuid volumes.
The relevance of Guyton’s model to modern
cardiovascular physiology
Guyton was a pioneer of ‘quantitative systems analysis’,
and his body of work clearly illustrated the power of
such an approach when combined with physiological
experimentation. It is important to stress that, while
model building does involve insight and intuition, trial
and error, the underlying components and parameters of
Guyton’s model were based on empirical data. Indeed,
Guyton did not discover or invent the PNR or tissue blood
ﬂow autoregulation or the Frank–Starling relationship;
his contribution was in bringing these well-described
phenomena together in amanner that revealed remarkable
insights about their role in cardiovascular regulation.
Such insights led to countless cycles of experimentation,
model reﬁnement, further experimentation and so on.
As Dr Guyton pointed out, the most helpful contribution
of the model was when it failed to correctly predict an
empirical outcome, since that clearly indicated a limitation
in our understanding of the system.
Guyton’s model was initially developed in the sixties
when computing power was poor and computer memory
was scarce and expensive. Simpliﬁcations weremandatory
to accommodate a large number of cardiovascular
relationships. Shortcuts in solving equations were also
required in order to runmonths of simulated experiments
in a reasonable computing time. Over the years, the
model evolved, the kidney acquired more details and
atrial natriuretic peptide was included, but the core of
the model and the basic concepts remained untouched.
Although Guyton’s model focuses on steady-state analysis
and does not include the most recent cardiovascular
discoveries, many of the principles contained in the
original model have been incorporated by others into
advancedmodels that elaborate on individual components
or provide a more comprehensive representation of the
entire circulation and its control by various inﬂuences,
including the CNS (Karaaslan et al. 2005; Abram et al.
2007). Thus, Guyton’s contributions continue to serve as
a ﬁrm foundation on which contemporary cardiovascular
modellers can build.
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